Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 13,883

Document Document Title
WO/2018/012459A1
An oxygen separation membrane which is configured of a porous material and a complex in the form of a liquid, said complex being internally contained in the porous material, and wherein: the complex contains a metal salen complex or a de...  
WO/2018/004945A1
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):  
WO/2017/222043A1
The purpose of the present invention is to provide: a crystal of HMB amino acid salt, which is easy to handle and is highly soluble; and a production method of said crystal. According to the present invention, a crystal of HMB amino acid...  
WO/2017/222921A1
Substituted derivatives of 2-hydroxyisophthalic acid are provided, as well as new synthetic routes for making 2-hydroxyisophthalic acid and the substituted derivatives. Potential uses of the derivatives in a variety of applications are a...  
WO/2017/221079A1
The present invention relates to a mycotoxin adsorbant based on a betaine derivative and highly specific for type A and B trichothecenes, especially for vomitoxin (or deoxynivalenol) and T-2 toxin, and to a method for preparing said myco...  
WO/2017/220308A1
Process for making a powder or granule containing at least one chelating agent selected from alkali metal salts of methyl glycine diacetic acid (MGDA) and glutamic acid diacetate (GLDA) and iminodisuccinic acid (IDS), said process compri...  
WO/2017/216299A1
The object of the present invention are compounds comprising at least one donor group and at least one acceptor group, as described herein, which are characterized by a pronounced CT character. The invention also relates to the use there...  
WO/2017/209117A1
The present invention relates to a detergent composition for fibres which includes: component (A), namely C17-24 internal olefin sulfonates; component (B), namely a nonionic surfactant; and component (C), namely a metal ion chelating age...  
WO/2017/208258A1
The present invention discloses a novel process for the preparation of gadolinium complex of (4S)-4-(4-Ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioic acid disodium of formula 1 and novel intermediates thereof.  
WO/2017/205588A1
This document relates to an aqueous composition comprising chlorambucil and human serum albumin, wherein the chlorambucil and the human serum albumin in the aqueous composition have a ratio by weight from about 1:10 to about 1:2000, wher...  
WO/2017/199513A1
The present invention addresses the problem of providing a liquid crystal composition which does not require an alignment treatment or an alignment film on the substrate, and solves this problem by providing a low molecular polar compoun...  
WO/2017/199514A1
The present invention addresses the problem of providing a liquid crystal display element that has a liquid crystal composition which does not require an alignment treatment or an alignment film on the substrate, and solves this problem ...  
WO/2017/199512A1
The present invention addresses the problem of providing a liquid crystal composition which does not require an alignment treatment or an alignment film on the substrate, and solves this problem by providing a low molecular polar compoun...  
WO/2017/199227A1
The present invention relates to a simple economical process for the preparation of 3,4- dihydroxy-2-methyl benzoic acid C1-4 alkyl ester and novel intermediates for use in the process.  
WO/2017/191453A1
A metal-EDTA compound/complex for combatting biofilms and/or treating wounds. The compound/complex comprises EDTA and from two to four metal ions. Of those two to four metal ions, at least two are different metal ions selected from Ag, A...  
WO/2017/189311A1
Glycan Composites and methods for rendering glycan composites for the treatment of photosynthetic organisms, including the steps of formulating branched glycan deglycosylates into coordination complex compositions resulting in water-born...  
WO/2017/183539A1
[Problem] To provide a compound that can be used on an industrial scale. [Solution] A compound represented by general formula (4) or a base adduct thereof. (In the formula, R3 and R4 independently represent a hydrogen atom or the like.)  
WO/2017/183734A1
Provided is an amino acid derivative prodrug represented by general formula (I-A) that is a prodrug form of an amino acid derivative which is a group 2 metabotropic glutamate receptor antagonist, or a pharmaceutically acceptable salt the...  
WO/2017/181118A1
The present invention provides methods for producing cannabinoid prodrugs. Also described are pharmaceutically acceptable compositions of the prodrugs and a system for the large-scale production of the prodrugs.  
WO/2017/176974A1
The present disclosure relates to a series of biodegradable amino-ester lipid-like nanoparticles. In some embodiments, the biodegradable amino-ester lipid-like nanoparticles are used in methods for the delivery of nucleic acids.  
WO/2017/173019A1
This invention relates to novel compositions comprising the reaction product of at least one acetoacetylated polyol and vanillin. The invention also relates to a method of making the novel compositions of the invention comprising the rea...  
WO/2017/168313A1
The present invention provides an improved process for preparation of L-threo-(2S,3R)-3-(3.4- dihydroxyphenyl)serine (I) (Droxidopa) and its salts; comprising (a) reaction of the aldehyde compound (III) (as described herein) with Metal c...  
WO/2017/164363A1
The present invention provides a liquid softener composition, which is capable of controlling generation of a sulfur-like odor while continuously realizing the fragrance intended in design and which has excellent storage stability at a l...  
WO/2017/161095A1
Provided herein are rigid macrocycles comprising a first redox-active subunit and a second redox-active subunit, wherein the first redox-active unit and the second redox-active unit are different subunits. Also provided herein are method...  
WO/2017/160784A1
The present invention provides energy-curable compositions comprising aminoacrylates produced by the Michael addition reaction of any blend of highly alkoxylated monomers with any blend of mono- and/or bireactive amines. Suitable highly ...  
WO/2017/160709A1
A compound that is selected from the group consisting of 3-(3,4-dichloroanilino)-3-oxopropanoic acid (hereinafter "DCOPA"); N-methyl-DCOPA; N,2-dimethyl-DCOPA; 2-methyl-DCOPA; isobutyl-DCOPA; N-methyl-isobutyl DCOPA; 3-(3,4-bibromoanilin...  
WO/2017/156164A1
The present invention concerns compounds and their use to treat cardiovascular disease, renal disease, thrombic disease, stroke, metabolic syndrome, cell proliferation, and ischemic cardiovascular disorders. Compounds of the present inve...  
WO/2017/154738A1
The present invention addresses the problem of providing a novel method for producing an optically active amine compound that is useful as an intermediate for a medicine, an agrochemical, an electronic material and the like. A method for...  
WO/2017/145097A2
The invention relates to amino acid and peptide conjugates, methods for making amino acid and peptide conjugates, conjugates produced by the methods, and pharmaceutical compositions comprising the conjugates. Methods of eliciting immune ...  
WO/2017/145097A3
The invention relates to amino acid and peptide conjugates, methods for making amino acid and peptide conjugates, conjugates produced by the methods, and pharmaceutical compositions comprising the conjugates. Methods of eliciting immune ...  
WO/2017/137955A1
The present invention relates to novel chiral 3-(2-(allyloxy)-5-methylphenyl)-N,N-diisopropyl-3-phenylprop an-1-amine (5) and racemic 3-(2-(allyloxy)-5-methylphenyl)-N,N-diisopropyl-3-phenylprop an-1-amine () and its use in improved and ...  
WO/2017/133517A1
Disclosed are a phosphamide derivative, a method for manufacturing the same, and uses thereof Particularly disclosed are a compound shown by general formula (I) as well as a pharmaceutically acceptable salt or stereisomer (I) thereof, wh...  
WO/2017/132912A1
The present invention provides an alkylamine with a benzoalicyclic substituent and an application thereof. More specifically, the invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a...  
WO/2017/133913A1
The present invention relates to a process for the N-alkylation of amines by reacting an amine with an orthocarboxylic acid ester and with hydrogen in the presence of a hydrogenation catalyst.  
WO/2017/133429A1
The present invention discloses a terpineol and a preparation method and an application thereof. The terpineol has a structure represented by formulas (I) or (II). In formula (I), R is independently selected from C12 to C16 alkyl, -NR1R2...  
WO/2017/134212A1
The present invention relates to a one-pot process for the preparation of trans-4-amino-l-cyclohexanecarboxylic acid derivatives where the trans ratio is more than 75% by reaction of a 4-aminobenzoic acid derivative using an appropriate ...  
WO/2017/131097A1
Provided is a pharmaceutical composition for the treatment or prevention of a cognitive disease or disorder, the composition comprising a compound represented by formula (1), an enantiomer thereof or diasteriomer thereof, or a pharmaceut...  
WO/2017/131149A1
A compound shown by general formula (I-1) (in the formula, all symbols are as stated in the specification.) has selective S1P5 receptor-binding activity. Adjusting this activity makes it possible to obtain a therapeutic agent for S1P5-me...  
WO/2017/131237A1
Provided are: a novel artificial single guide RNA (sgRNA) that has an activity equal to or higher than the activity of a natural type sgRNA and shows an improved in vivo stability; and an efficient CRISPR/Cas9 system comprising a combina...  
WO/2017/132178A3
The present disclosure provides new salts of 5-aminolevulinic acid (5-ALA) and new salts of 5-ALA esters, their preparation, formulation and use as photosensitizing agents in photodynamic therapy, diagnosis and cosmetic cares.  
WO/2017/130687A1
[Problem] To make the size and shape of obtained particles uniform. Proposed is a mode by which the power cost is not increased. [Solution] A method of producing particles for which contact is brought about between a plurality of dissimi...  
WO/2017/125673A1
The invention relates to a method for preparing a compound (I) or one of the salts thereof, and the uses of said method, R1OOC-C(=X)-CHR2 R3 (I), wherein X is selected among O; N-R', wherein R' is H or a C1-C6 alkyl; and N-OR'' wherein R...  
WO/2017/122121A1
This present invention relates to a method of stabilizing an aqueous pharmaceutical preparation susceptible to degradation by formulating in a dual buffer system wherein the individual buffers are selected from phosphate, aspartate, glut...  
WO/2017/117124A1
A crosslinkable hole transport molecule having four radical polymerizable groups to be used in a photoconductor to provide a medium for hole transport upon exposure to light and method to make the same is provided. Photoconductors using ...  
WO/2017/113428A1
Disclosed are a method for synthesizing a number of aliphatic cyanoamino acids and application of the cyanoamino acids in bioorthogonal Raman detection. The aliphatic cyanoamino acids are methionine derivatives and lysine derivatives. Th...  
WO/2017/114225A1
The present invention relates to a fused tricyclic γ-amino acid derivative and a pharmaceutical application thereof. Specifically, the present invention relates to a fused tricyclic γ-amino acid derivative depicted by general formula (...  
WO/2017/107907A1
The present invention relates to a condensed ring γ-amino acid derivative and a medical use thereof, and in particular relates to the condensed ring γ-amino acid derivative as shown in formula (I), or a stereisomer, a solvate, a metabo...  
WO/2017/108884A1
It is provided a compound of formula (I'); wherein R5 is selected from the group consisting of -H, -OM, -COOM, -NH2, -SO3M, (C1-C4)alkyl, and halogen; and A is a radical having at least 3 C atoms selected from the group consisting of: i)...  
WO/2017/102483A1
Process for manufacturing a crystalline alkali metal salt of the general formula (I) [R1-CH(COO)-N(CH2-COO)2]M1 3 (I) wherein M1 is selected from alkali metal cations, same or different, R1 is selected from C1-C4-alkyl and CH2CH2COOM1, c...  
WO/2017/105090A1
The present invention provides the Form 1 crystalline polymorph of L-carnitine orotate, a production method therefor, and a use thereof. The Form 1 crystalline polymorph of L-carnitine orotate of the present invention can be used as a ph...  

Matches 1 - 50 out of 13,883